KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Liabilities: 2015-2025

Historic Total Liabilities for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $1.5 billion.

  • Medpace Holdings' Total Liabilities rose 21.35% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 21.35%. This contributed to the annual value of $1.3 billion for FY2024, which is 16.16% up from last year.
  • As of Q3 2025, Medpace Holdings' Total Liabilities stood at $1.5 billion, which was up 4.29% from $1.4 billion recorded in Q2 2025.
  • Medpace Holdings' 5-year Total Liabilities high stood at $1.5 billion for Q3 2025, and its period low was $592.4 million during Q1 2021.
  • Moreover, its 3-year median value for Total Liabilities was $1.2 billion (2024), whereas its average is $1.2 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first spiked by 67.07% in 2022, then decreased by 1.58% in 2023.
  • Quarterly analysis of 5 years shows Medpace Holdings' Total Liabilities stood at $707.0 million in 2021, then spiked by 36.65% to $966.1 million in 2022, then rose by 13.64% to $1.1 billion in 2023, then climbed by 16.16% to $1.3 billion in 2024, then climbed by 21.35% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.3 billion during Q1 2025.